About Tom Insel
Form D filings for Neurawell Therapeutics in 2024 list Tom Insel as executive officer and director.
Tom Insel first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Tom Insel in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tom Insel works with at each company, as listed on that company's latest Form D.
Neurawell Therapeutics, Inc. · Form D, Jun 10, 2024
JA
Jack Abraham
Director
MA
Magid Abraham
Chief Executive Officer and director